Jonathan A. Race

Jonathan A. Race, PhD

Languages spoken: English

Academic Information

Departments Primary - Pediatrics , Adjunct - Family & Preventive Medicine , Adjunct - Pediatrics

Divisions: Critical Care

Research Interests

  • Hierarchical and Mixed Models
  • Bayesian Non- and Semi-Parametric Models
  • Collaborative Research
  • Clinical Trials
  • Survival Analysis
  • Bayesian Inference

Dr. Race joined the University of Utah School of Medicine’s Department of Pediatrics as an assistant professor in early 2022. His academic career began here at the University of Utah where he studied mathematics and philosophy as an undergrad. Dr. Race completed a PhD in biostatistics at the Ohio State University Department of Public Health in 2019. His dissertation was concerned with Bayesian semi-parametric survival analysis. Post graduate school, Dr. Race took a position as a clinical trials statistician at the pharmaceutical company Eli Lilly where he worked on trial design and submission for studies concerning immunological diseases and Covid. Dr. Race’s research interests include Bayesian trial design, analysis of time-to-event data, non- and semi-parametric modeling, and longitudinal analysis.

Education History

Doctoral Training The Ohio State University
 PhD
Undergraduate University of Utah
 BS

Selected Publications

Journal Article

  1. Race JA, Ruppert AS, Efebera Y, Pennell ML (2025). Semi-parametric testing for ordinal treatment effects in time-to-event data via dynamic Dirichlet process mixtures of the inverse-Gaussian distribution. Stat Methods Med Res, 9622802251322986. (Read full article)
  2. MacRae R, Race J, Schuette A, Waltz M, Casper TC, Rose J, Abrams A, Rensel M, Waubant E, Virupakshaiah A, Schoeps V, ONeill K, Ness J, Wheeler Y, Shukla N, Mar S, Rodriguez M, Chitnis T, Gorman M, Benson L (2025). Limited early IVIG for the treatment of pediatric myelin oligodendrocyte glycoprotein antibody-associated disease. Mult Scler Relat Disord, 97, 106345. (Read full article)
  3. Virupakshaiah A, Schoeps VA, Race J, Waltz M, Sharayah S, Nasr Z, Moseley CE, Zamvil SS, Gaudioso C, Schuette A, Casper TC, Rose J, Flanagan EP, Rodriguez M, Tillema JM, Chitnis T, Gorman MP, Graves JS, Benson LA, Rensel M, Abrams A, Krupp L, Lotze TE, Aaen G, Wheeler Y, Schreiner T, Waldman A, Chong J, Mar S, Waubant E (2024). Predictors of a relapsing course in myelin oligodendrocyte glycoprotein antibody-associated disease. J Neurol Neurosurg Psychiatry. (Read full article)
  4. Yellepeddi VK, Race JA, McFarland MM, Constance JE, Fanaeian E, Murphy NA (2024). Effectiveness of atropine in managing sialorrhea: A systematic review and meta-analysis. Int J Clin Pharmacol Ther, 62(6), 267-277. (Read full article)
  5. Loaec M, Himebauch AS, Reeder R, Alvey JS, Race JA, Su L, Lasa JJ, Slovis JC, Raymond TT, Coleman R, Barney BJ, Kilbaugh TJ, Topjian AA, Sutton RM, Morgan RW, American Heart Associations AHA Get With The Guidelines-Resuscitation GWTG-R Investigators (2023). Outcomes of Extracorporeal Cardiopulmonary Resuscitation for In-Hospital Cardiac Arrest Among Children With Noncardiac Illness Categories. Crit Care Med, 52(4), 551-562. (Read full article)
  6. Nigrovic LE, Chun TH, Vargas SE, Caffrey AR, Halperin JJ, Race JA, Ott U, Morrison BL, Fuller BJ, VanBuren JM, Lyme Net P (2023). Comparative effectiveness and complications of intravenous ceftriaxone compared with oral doxycycline in Lyme meningitis in children: a multicentre prospective cohort study. BMJ Open, 13(2), e071141. (Read full article)
  7. Ranganathan M, Kostyk SK, Allain DC, Race JA, Daley AM (2020). Age of onset and behavioral manifestations in Huntington's disease: An Enroll-HD cohort analysis. Clin Genet, 99(1), 133-142. (Read full article)
  8. Race JA, Pennell ML (2021). Semi-parametric survival analysis via Dirichlet process mixtures of the First Hitting Time model. Lifetime Data Anal, 27(1), 177-194. (Read full article)